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angerhans cells (LC) form a unique subset of dendritic
cells (DC) in the epidermis but so far their in vivo
functions in skin immunity and tolerance could not be
determined, in particular in relation to dermal DC (dDC).
Here, we exploit a novel diphtheria toxin (DT) receptor
(DTR)/DT-based system to achieve inducible ablation of
LC without affecting the skin environment. Within 24 h
after  intra-peritoneal injection of DT into Langerin-DTR
mice LC are completely depleted from the epidermis
and only begin to return 4 wk later. LC deletion occurs by
L
 
apoptosis in the absence of inﬂammation and, in particular,
the dDC compartment is not affected. In LC-depleted mice
contact hypersensitivity (CHS) responses are signiﬁcantly
decreased, although ear swelling still occurs indicating
that dDC can mediate CHS when necessary. Our results
establish Langerin-DTR mice as a unique tool to study LC
function in the steady state and to explore their relative
importance compared with dDC in orchestrating skin
immunity and tolerance.
 
Introduction
 
Dendritic cells (DC) are professional antigen presenting cells
specialized to induce and regulate T cell immunity and toler-
ance (Banchereau and Steinman, 1998; Steinman and Nussen-
zweig, 2002). Initiation of immune responses and maintenance
of self-tolerance are believed to rely on the mobilization of
sentinel DC to regional lymph nodes (LNs) where they interact
with naive antigen-specific T cells. Langerhans cells (LC) are
the resident DC population in skin epidermis where they form a
contiguous network to detect any invading pathogen or antigen
(Romani et al., 2003). Underlying the epidermis, the skin con-
tains a second DC population, dermal DC (dDC), which are
phenotypically, and may be functionally, distinct from LC. Due
to their position in the epidermis, LC have classically been
thought to play a pivotal role in the initiation and control of
skin (auto-)immunity and allergy (Schuler and Steinman, 1985;
Cumberbatch et al., 2003; Romani et al., 2003). However, this
notion has recently been challenged by findings that LC do not
initiate protective T cell responses to certain viral antigens
(Allan et al., 2003; Zhao et al., 2003) and 
 
Leishmania major
 
parasites (Ritter et al., 2004). Instead, protection from these
infections depends on LN antigen presentation and T cell acti-
vation by dDC. The functional role of LC in T cell priming thus
remains unclear. Furthermore, the relative importance of LC
compared with dDC in sensitization to chemical allergens and
elicitation of cutaneous contact hypersensitivity (CHS) responses
is still elusive.
Both LC and dDC constitutively migrate from the skin at
a low rate (Hemmi et al., 2001) and skin-draining LN contain
LC immigrants as well as interstitial DC derived from the
dermis (Anjuere et al., 1999; Ruedl et al., 2000; Henri et al.,
2001). This homeostatic turnover increases under inflammatory
conditions and dDC appear in the LN as early as 24 h after skin
painting, whereas LC require 3–4 d to migrate from the epidermis
(Kamath et al., 2002). Recently, it has been shown that the first
wave of antigen presentation to naive CD4 T cells occurs by
the two LN-resident skin-derived DC subtypes, which acquire
subcutaneously injected antigen from the lymph (Itano et al.,
2003). Interestingly, this presentation only leads to transient
T cell activation and the generation of a delayed type hyper-
sensitivity response requires cell-associated trafficking of
cutaneous antigen to the regional LN.
An effective approach to study the function of defined
cell populations or lineages in the intact animal is by their
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inducible and specific ablation in vivo. One strategy exploits
the insensitivity of mouse cells to killing by diphtheria toxin
(DT; Pappenheimer et al., 1982). The cytotoxicity of DT is
strictly dependent on receptor-mediated endocytosis (Naglich et
al., 1992) and resistance of murine cells results from the low af-
finity of the toxin for the rodent DT receptor (DTR). Thus,
transgenic expression of a primate DTR in mice confers DT
sensitivity to murine cells (Saito et al., 2001), which are thought
to die by apoptosis (Morimoto and Bonavida, 1992; Thorburn et
al., 2003). This DTR/DT system has been successfully used to
achieve conditional ablation of DC in CD11c-DTR mice (Jung
et al., 2002). In these mice a single injection of DT lead to rapid
depletion of CD11c
 
 
 
 cells for 2 d after which the DC compart-
ment was gradually restored to wild-type (wt) numbers by day 6.
Langerin is a C-type lectin specifically expressed by LC
(Takahara et al., 2002; Valladeau et al., 2002). To target DT
sensitivity to LC, we generated mice that harbor a targeted in-
sertion of a primate DTR in the Langerin locus. Here, we report
the inducible ablation of LC in adult Langerin-DTR mice
within 24 h after injection of DT. LC depletion is complete,
specific and occurs by apoptosis without inducing inflamma-
tion of the skin. We show that reconstitution of the epidermal
LC compartment in the steady state takes at least 4 wk and ap-
pears to originate in situ. Functional analysis of LC-depleted
mice reveals that dDC are able to mediate a cutaneous CHS
response, but supports an essential role for LC in the elicitation
of optimal allergic reactions to topically applied hapten.
 
Results and discussion
 
Generation of Langerin-DTR mice
 
A powerful means of investigating the functional role of de-
fined cell populations is via their ablation in vivo. This can be
achieved by cell type–specific expression of a primate DTR,
which induces apoptotic cell death upon binding and internal-
ization of DT (Morimoto and Bonavida, 1992; Saito et al.,
2001; Thorburn et al., 2003). Previously, we have identified
the mouse homologue of the human Langerin gene and con-
firmed its LC-specific expression (Takahara et al., 2002). For
highly efficient and inducible depletion of LC, we generated
Langerin-DTR knockin mice (Fig. 1). Specifically, a simian
DTR:EGFP cassette (Jung et al., 2002) was inserted into the
second exon of the Langerin gene via homologous recombina-
tion in embryonic stem (ES) cells (Fig. 1 A). To ensure effi-
cient translation of the DTR:EGFP fusion protein, all ATG
codons upstream of the DTR cDNA were mutated. The lin-
earized vector was electroporated into C57BL/6 ES cells
(Bruce4; Köntgen et al., 1993). Correctly targeted ES cell
clones were identified by genomic Southern blot using a 5
 
 
 
 ex-
ternal probe outside the homology arm and subsequently con-
firmed to be single-copy integrants with the internal DTR:
EGFP cDNA probe (Fig. 1, A and B; not depicted). Two inde-
pendent targeted ES cell clones were injected into blastocysts
for the generation of chimeras. After germline transmission of
the mutation, the Langerin-DTR line was established by cross-
ing one founder with an ACTFlpe mouse (Rodriguez et al.,
2000) to excise the FRT-flanked neomycin (Neo
 
R
 
) cassette.
Deletion of the selection marker was confirmed by genomic
Southern blot and sequence analysis (Fig. 1, A and C; not de-
picted). The Langerin-DTR mice are maintained as heterozy-
gotes, are healthy, and breed normally. They are routinely
genotyped by PCR (Fig. 1 D). 
 
Efficient and specific long-term ablation 
of LC upon injection of DT
 
Both during initial seeding of the epidermis in fetal life (Tripp
et al., 2004) and repopulation of the epidermis after mechanical
disruption (Holzmann et al., 2004) major histocompatability
complex class II (MHCII) precedes expression of Langerin.
Therefore, we monitored depletion and repopulation of LC by
Figure 1. Generation of Langerin-DTR mice. (A) Schematic
representation of the targeting strategy used for the
generation of Langerin-DTR mice. HR, homologous recom-
bination; K, KpnI; E, EcoRI; N, NotI. (B) Identification of
targeted ES cell clones by Southern hybridization using
probe [1] after digestion with KpnI, 8-kb wt allele and 3-kb
targeted allele.  / , wt;  /t, targeted heterozygote.
(C) Depletion of the Neo
R cassette was verified by Southern
blot analysis using the DTR:GFP cassette as probe [2]:
 , Langerin-DTR founder; wt, wt control;  Neo, Langerin-
DTR Neo. (D) Genomic PCR of Langerin-DTR mice, lanes
1–5, Langerin-DTR mutant and wt littermates;  , Langerin-
DTR founder; –, water control. 
INDUCIBLE LANGERHANS CELL DEPLETION IN MICE • BENNETT ET AL.
 
571
 
MHCII. As investigated by fluorescence microscopy of epider-
mal ear sheets, LC develop normally in Langerin-DTR mice
(Fig. 2 A and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200501071/DC1). However, highlighting their
toxin sensitivity LC are rapidly and completely ablated upon
i.p. injection of DT (Fig. 2 A). The vast majority of LC appear
to be depleted within 24 h of injection and at 48 h the ear epi-
dermis is devoid of LC. Interestingly, LC do not repopulate the
epidermis during 4 wk after injection of DT (Fig. 2 B) and at
this time point individual foci (“patches”) of MHCII
 
 
 
 LC be-
Figure 2. Efficient and specific ablation of LC from Langerin-DTR mice. (A) Epidermal sheets were separated from mouse ears and stained for MHCII to
visualize LC: (a) wt; (b) wt   DT (72 h); (c) Langerin-DTR. Mutant mice were subsequently injected i.p. with DT and LC visualized to determine the kinetics
of depletion and repopulation; (d) 24 h; (e) 48 h; (f) 2 wk; (g–i) 4 wk. Pictures are representative of four different mice for each time point,   adjustments
were made to reduce background on epidermal sheets. Cross sections through ear skin were stained with MHCII to demonstrate selective depletion of LC and
an intact dDC compartment after DT. (j) Langerin-DTR; (k) DTR   DT (24 h). Arrowheads identify MHCII
  LC in the epidermis. Bars, 50  m. (B) Quantification
of depletion and repopulation of LC after injection of DT. Numbers of MHCII
  LC were counted using a gridded eyepiece with the 40  objective.
20 fields of evenly spaced cells were counted from four different mice for each time point. At 6 wk after injection of DT, LC numbers are still significantly
decreased compared with wt mice (Mann-Whitney test wt vs. Langerin-DTR mice at 6 wk: P   0.0286). Error bars represent SD. (C) LC but not dDC are
ablated in Langerin-DTR mice. Emigrant cells from the epidermis or dermis of wt and Langerin-DTR mice injected with DT 48 h earlier were analyzed by
flow cytometry. Numbers show the percentage of CD11c/MHCII double-positive cells, FACS plots are representative of three separate experiments. 
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come visible in the epidermal sheets (Fig. 2 A). Even at 8 wk LC
reconstitution is incomplete and, in addition, the cells that re-
turn from 4 wk onwards appear to have more extended den-
drites “reaching out” into the intercellular space. Therefore,
fewer LC cover the same surface area compared with before
DT deletion (unpublished data). As expected, there is no ad-
verse effect of DT on LC of wt mice and, importantly, dDC are
still present after injection of DT into Langerin-DTR mice (Fig.
2 A).
These histological observations were confirmed by flow
cytometry of cells that emigrated in vitro from epidermal and
dermal sheets, respectively (Fig. 2 C). At 48 h after DT injec-
tion, CD11c
 
 
 
MHCII
 
 
 
 LC are reduced by 95.4% 
 
 
 
 1.18 (mean 
 
 
 
SEM, 
 
n
 
 
 
 
 
 6). The reduction of dermal CD11c
 
 
 
MHCII
 
 
 
 cells
(19.4% 
 
 
 
 4.9, 
 
n
 
 
 
 
 
 6) can be attributed to loss of LC in transit
on their homeostatic migration to the local LN. In addition,
upon separation small areas of epidermis inevitably remain at-
tached to the dermal sheet (Stoitzner et al., 2003).
Recently, the DTR/DT system was used to efficiently de-
lete DC within 24 h of systemic injection of DT (4 ng/g body
weight) into CD11c-DTR transgenic mice (Jung et al., 2002).
To ensure that sufficient concentrations of DT were reached at
the epithelial border to the outside world, Langerin-DTR mice
were treated with 16 ng DT/g body weight throughout our ex-
periments. However, doses as low as 2 ng/g body weight yield
near complete depletion of the LC after 48 h (Fig. S2, available
at http://www.jcb.org/cgi/content/full/jcb.200501071/DC1).
In contrast to CD11c-DTR mice, in which DC numbers
recover to pre-DT treatment levels within 5–6 d (Jung et al.,
2002), the first signs of LC repopulation of the epidermis in
DT-injected Langerin-DTR mice become evident only after 4
wk (Fig. 2 A), in agreement with the low steady-state turnover
of LC (Merad et al., 2002). There are multiple hypotheses to
explain the return of LC in LC-depleted mice: On one hand, LC
may recover due to in situ proliferation of a dedicated Lan-
gerin
 
negative
 
 LC precursor, or rare LC which escaped DT-medi-
ated deletion; alternatively, LC reconstitution may be the result
of de novo immigration, differentiation, and proliferation of LC
precursors and/or monocytes into the epidermis (Merad et al.,
2002; Holzmann et al., 2004). In the absence of any inflamma-
tory mediators attracting LC precursors to move into the epi-
dermis and considering the focal nature of initial repopulation
Figure 3. EGFP expression in Langerin-DTR
mice. (A) Expression of EGFP in Langerin-DTR
epidermal sheets. Visualization of EGFP expres-
sion was enhanced by incubation of an anti–
GFP-488 antibody, which specifically labeled
cells from Langerin-DTR mice. Bars, 50  m. (B)
EGFP expression in skin draining LN. CD11c
 
LN cells from wt, Langerin-DTR, and Langerin-
DTR mice injected with DT (48 h) were enriched
and analyzed for EGFP expression, 3.34%  
0.375 (mean   SEM, n   4) of LN cells were
gated EGFP-positive compared with 1.47%  
0.121 (n   4) background fluorescence in wt
mice. Mann-Whitney test wt vs. Langerin-DTR,
P   0.0159. FACS plots are representative of
four different experiments. (C) Cells from
Langerin-DTR mice were analyzed for expres-
sion of surface markers and CD11c. Blue dots
are gated EGFP
  cells from B. Plots are rep-
resentative of at least five different experiments.
(D) LNs from Langerin-DTR mice or Langerin-DTR
mice injected with DT for 48 h were sectioned
and analyzed for the presence of EGFP
  LC.
All sections were stained with anti–GFP-488
in addition to anti-B220 (a and b) or anti-
MHCII (c) to demarcate B and T cell areas,
respectively. Bars, 10  m. 
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of the epidermal LC niche, we currently favor local differentia-
tion and proliferation of in situ LC or LC precursors as the
most likely mechanism of LC reappearance, and are investigat-
ing this hypothesis further.
 
Langerin-driven EGFP expression in 
Langerin-DTR mice
 
In Langerin-DTR mice, the Langerin promoter drives expres-
sion of a DTR:EGFP fusion protein (Fig. 1 A). By fluorescence
microscopy of epidermal sheets, we can detect EGFP
 
 
 
 LC,
which vanish upon injection of DT (Fig. 3 A and not depicted).
However, even using an anti-GFP antibody for detection, the
staining appears to be less intense than that observed with anti-
MHCII and we are unable to visualize all LC which, based on
their susceptibility to DT-mediated killing, we would expect to
be EGFP
 
 
 
 (compare Fig. 2 A with Fig. 3 A).
Flow cytometry of skin-draining LN of Langerin-DTR
mice reveals a distinct CD11c
 
 
 
EGFP
 
 
 
 DC subpopulation,
which corresponds to 3.34% 
 
 
 
 0.375 (mean 
 
 
 
 SEM) of all
CD11c
 
 
 
 LN cells (Fig. 3 B). As demonstrated in Fig. 3 C, these
EGFP
 
 
 
 LN DC are CD40
 
high
 
 and CD8
 
 
 
low
 
 and, thus, most
likely represent recent epidermal skin immigrants (Henri et al.,
2001; Stoitzner et al., 2003). By immunohistochemistry, the
Langerin-EGFP
 
 
 
 DC are confined to the T cell area where LC-
derived DC interact with naive antigen-specific T cells (Fig. 3
D). Upon injection of DT this skin-derived EGFP
 
 
 
 LN DC
subset is readily depleted (Fig. 3, B and D). Careful examina-
tion of EGFP expression by colocalization with MHCII reveals
that there are very few EGFP
 
 
 
 cells in thymus and spleen; al-
though they are clearly present in the thymus, it is very difficult
to detect any EGFP
 
 
 
 cells in the spleen (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200501071/DC1). These
observations are in contrast to published data using anti-Lan-
gerin antibodies (Valladeau et al., 2002; Stoitzner et al., 2003).
As is evident from Fig. 3 A, Langerin-driven EGFP expression
may not allow detection of all cells that should be EGFP
 
 
 
.
Therefore, we do not know if this discrepancy is due to an un-
derestimation in the Langerin-DTR mice or reflects a genuine
functional difference.
 
Depletion of LC in the absence of 
inflammation
 
One of the important advantages of DTR/DT-mediated LC de-
pletion compared with conventional techniques, namely ste-
roids (Grabbe et al., 1995), UV-B irradiation (Merad et al.,
2002) or repeated tape stripping (Holzmann et al., 2004), is ef-
ficient ablation of LC without any apparent adverse side ef-
fects. In particular, there is no induction of skin inflammation
as DT induces apoptosis by inhibition of protein synthesis and
activating components of the death receptor pathway (Mori-
moto and Bonavida, 1992; Thorburn et al., 2003). Tissue integrity
was demonstrated by visualizing a wt dendritic epidermal 
 
  
 
 T
cell network in DT-treated Langerin-DTR mice (Fig. 4). In ad-
dition, we failed to detect any cell infiltration or inflammatory
ear swelling in response to DT-induced LC death (unpublished
data). Upon injection of DT, LC disappear from the epidermis
so rapidly that it would be difficult to demonstrate their death
by apoptosis in situ. Therefore, epidermal emigrants from ears
of Langerin-DTR and wt mice were incubated with DT in vitro.
The specific appearance of AnnexinV
 
 
 
 cells in cultures from
Langerin-DTR, but not wt, mice supports our hypothesis of
apoptotic LC death (unpublished data). Thus, LC-depleted
Langerin-DTR mice represent immunologically naive, resting
animals with no other obvious phenotype except their lack of
LC. Therefore, they provide a unique tool to study the role of
LC and their LN descendants in the steady state, for instance, in
the induction of peripheral tolerance to cutaneous antigens.
 
Reduced CHS in the absence of LC
 
Murine CHS is a prototypic T cell response to haptens painted
onto the skin. Priming of naive hapten-specific T cells, during
the asymptomatic sensitization phase, is thought to be mediated
by LC. Re-exposure to the relevant hapten then initiates the ef-
ferent phase and development of disease (Grabbe and Schwarz,
1998). Although LC have been strongly linked to the initiation
of CHS in vivo (Enk and Katz, 1992; Enk et al., 1993), their
function relative to dDC has not been determined. LC may also
play an, as yet undefined, role regulating the effector phase of
the allergic response.
To test the requirement for LC we induced a CHS re-
sponse in LC-depleted mice. 3 d after i.p. injection of DT,
when the epidermis is devoid of LC (Fig. 2, A and B), Lan-
gerin-DTR mice were sensitized to hapten by painting 1% tri-
nitrochlorobenzene (TNCB) on the abdomen. 5 d later, the ani-
mals were challenged by topical application of 0.5% TNCB
onto one ear and ear swelling was measured 24 and 48 h later.
As shown in Fig. 5, an allergic response is induced both in the
presence and absence of LC, which subsides with time. It is im-
portant to point out that hapten sensitization (abdomen) is spa-
tially separated from the site of elicitation of disease (ear) and
LC precursors do not repopulate the ear epidermis after sensiti-
zation (unpublished data). Therefore, LC are absent throughout
the entire CHS response and our data demonstrate that dDC are
sufficient for the initiation and elicitation of CHS.
Figure 4. Depletion of LC in the absence of inflammation.
Epidermal sheets from wt and Langerin-DTR mice injected
with DT were stained with an antibody against the   
TCR to visualize dendritic epidermal    T cells. Pictures
are representative of four different mice for each time
point.   adjustments were made to reduce background
on epidermal sheets. Bars, 50  m. 
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It is also evident from Fig. 5 that although dDC alone are
able to mediate CHS, the magnitude of the allergic response is
significantly reduced in the absence of LC. This finding contra-
dicts published data (Grabbe et al., 1995), which were, how-
ever, obtained using experimental conditions (steroids) known
to disturb the local microenvironment. It has recently been dis-
covered that distinct skin-derived DC populations sequentially
present antigen to CD4
 
 
 
 T cells with dDC, not LC, being the
first to carry cell-associated antigens to the LN for stimulation
of a delayed type hypersensitivity response (Itano et al., 2003).
Ongoing experiments extend these studies and aim to dissect
whether LC are required during the afferent and/or efferent
phase of CHS, to mediate an optimal allergic response.
To date it has not been possible to definitively assess the
relative antigen presentation contributions of LC and dDC in
skin immunity and tolerance. By inducible LC ablation in mice,
we show here that dDC are able to induce CHS to chemical al-
lergens, but LC are mandatory to provoke aggravated allergic
disease. Although the former may not be entirely unexpected
for hapten antigens likely to penetrate into the dermis, the latter
may allow the LC to redeem some of the credit they recently
seem to have lost (Serbina and Pamer, 2003). Our Langerin-
DTR mice represent a unique tool with which to unravel the
long-standing and more recent mysteries of LC function and de-
velopment, in particular, in relation to their dDC neighbors.
 
Materials and methods
 
Mice
 
Mice were housed in the animal facility of the AMC (Animal Research In-
stitute Amsterdam [ARIA], University of Amsterdam). All animal experimen-
tation was in compliance with EU as well as national laws and approved
by the local ethical committee (Dierexperimentencommissie, AMC).
 
Generation of Langerin-DTR mice
 
A 5-kb EcoRI fragment containing the putative promoter region and first
three exons of the Langerin gene was identified from a murine BAC clone
(Research Genetics) and subcloned into pBS as a base for the Langerin-
DTR targeting construct. All ATG codons before the intended DTR insertion
point in the second exon were subsequently mutated using two successive
sets of mutagenic primers, which included unique restriction sites for later
cloning steps. HSV-TK was released from pIC19R-MC1tk (Mansour et al.,
1988) and FRT2Neo from pFRT2neoA (Jung et al., 1993). Both selection
markers were cloned downstream of the Langerin homology arm, leaving
a unique SalI restriction site between the two cassettes. This restriction site
enabled introduction of the 3
 
 
 
 homology arm of the targeting vector after
PCR amplification from C57Bl/6 genomic DNA. The targeting construct
was completed by inserting DTR:EGFPbpA (modified from Jung et al.
(2002) by addition of a bpA tail) into a unique PmeI site created in exon
2. The final construct was linearized using NotI, precipitated, and resus-
pended in 100 
 
 
 
l of sterile PBS (25 
 
 
 
g DNA per 10
 
7
 
 ES cells). Electropo-
ration of ES cells (Bruce4; Köntgen et al., 1993; gift of A. Waisman, Uni-
versity of Mainz, Mainz, Germany) and the expansion of Neo
 
R
 
 clones
was performed at the AMC targeting facility.
 
Southern blot analysis of ES cell clones
 
Genomic DNA from ES cell clones was digested with KpnI and blotted
onto a nylon membrane (Genescreen plus; NEN Life Science Products).
The DNA was hybridized to an 
 
 
 
800-bp 5
 
 
 
 external probe, generated by
PCR (Lang-1, 5
 
 
 
-GGAATGGTACCATCAGCATTCAGGG-3
 
 
 
; Lang-2, 5
 
 
 
-
AGTGTTGCAGGGAATTCCCTGGTTG-3
 
 
 
), which yielded an 8-kb wt and
3-kb targeted band. Hybridization was performed using RapidHyb buffer
(Amersham Biosciences) at 65
 
 
 
C overnight. Membranes were washed
with 1
 
 
 
 SSC/0.1% SDS and exposed to Kodak XOMAT-AR film. Stripped
membranes were reprobed with a 1.4-kb EcoRI DTR:EGFP fragment to ex-
clude multiple integrants. Southern analysis revealed a single 7.6-kb and
600-bp bands. Positive clones were confirmed by digest with a different
enzyme (NcoI) and hybridization to a 425-bp DTR probe, giving a cor-
rectly targeted band size of 3.5 kb.
 
Genomic analysis of Langerin-DTR mice
 
Two correctly targeted ES cell clones were selected for the production
of chimeras. Germline transmission was verified by PCR and Southern
blot analysis as above. Mice were genotyped as described by Jung et
al. (2002) (DTR1, 5
 
 
 
-GCCACCATGAAGCTGCTGCCG-3
 
 
 
; DTR2, 5
 
 
 
-
TCAGTGGGAATTAGTCATGCC-3
 
 
 
). To delete the Neo
 
R
 
 cassette founder
mice were bred with ACTFlpe mice (Rodriguez et al., 2000) purchased
from The Jackson Laboratory. F1 offspring were analyzed by Southern:
KpnI-digested DNA was hybridized with the DTR:EGFP probe to give a
7.6-kb fragment in the original targeted allele, and a 6.1-kb fragment in
the 
 
 
 
Neo allele. This was confirmed by sequence analysis of the region
surrounding the resolved FRT site.
 
Injection of DT
 
DT was provided by B. Metz (The Netherlands Vaccine Institute, Bilthoven,
NL) as a concentrated 
 
Diphtheria
 
 culture supernatant, diluted in sterile
PBS, and 400 ng were injected i.p. per mouse corresponding to 16 ng/g
body weight.
 
Preparation of epidermal sheets and fluorescent microscopy
 
The dorsal and ventral halves of mouse ears were split mechanically and
floated on 20 mM EDTA/PBS at 37
 
 C for 90 min. Epidermal sheets were
then removed, fixed with ethanol, rehydrated in PBS, blocked with PBS/
0.5% BSA, and stained with anti–MHCII-PE, anti–   TCR-PE, or anti–GFP-
488, as appropriate, for 30 min at RT. After washing with PBS the epider-
mal sheets were mounted on slides with Vector shield mounting medium
(Vector Laboratories). Cryosections (5–6  m thick) were fixed in 4% PFA
and stained according to standard procedures with anti–MHCII-FITC (skin)
or anti-MHCII and anti-B220 followed by an anti–rat-Cy3 secondary anti-
body (lymphoid organs). Images were viewed at RT using a DMRA fluores-
cent microscope (objectives of 10 , 25 , or 40 ; Leica). Images were
captured using a Kx14 camera (Apogee Instruments, Inc.) and Image-Pro
Plus software. All antibodies were from BD Biosciences except anti–GFP-
488 (Molecular Probes, Inc.) and anti–rat Cy3 (Jackson ImmunoResearch
Europe Ltd.).
Monitoring EGFP fluorescence
All FACS data represent genuine Langerin-driven EGFP expression.
Throughout our immunohistochemical experiments, using an anti-GFP anti-
body did not alter the staining pattern compared with direct EGFP fluores-
cence. However, although EGFP
  LC were visible by themselves, the stain-
ing intensity was increased with the anti–GFP-488 antibody (Fig. 3 A). To
our surprise, F1 mice retaining the Neo
R cassette (Fig. 1 A) exhibited
brighter anti-GFP staining than Neo-deleted animals. This observation was
critical to enable visualization of EGFP
  cells in lymphoid organs by immu-
Figure 5. Depletion of LC results in sub-optimal CHS responses. Wt or
Langerin-DTR mice (n   6–8) injected with DT at day  3, were sensitized
on the abdomen with 1% TNCB and challenged 5 d later with 0.5%
TNCB on one ear. Swelling was measured as the difference between
the challenged and nonchallenged ear. Ear swelling responses were
compared using a repeated measures ANOVA; wt vs. DTR   DT: P   0.039.
One representative experiment out of three is shown. The two additional
experiments were performed with four mice per group.INDUCIBLE LANGERHANS CELL DEPLETION IN MICE • BENNETT ET AL. 575
nohistochemistry. Having extensively checked both mice we are certain
that there is no difference in the expression pattern of Langerin-driven
EGFP in the presence of the neo gene.
Isolation of LC and dDC
LC and dDC were isolated after washing mouse ears in 70% ethanol and
digestion of split ears in 1.2 U/ml dispase (Boehringer) for 30 min at
37 C. Epidermal and dermal layers were separated and cultured in 24-
well plates (one ear per well) in RPMI (GIBCO BRL)/10% FCS (PAA) with
 -mercaptoethanol and gentamycin (Sigma-Aldrich). 48 h later the cells
were passed through a 70- M cell strainer (BD Biosciences) to remove
any debris, and resuspended in PBS/1% FCS for flow cytometric analysis.
Enrichment of CD11c
  cells from lymphoid organs and flow cytometry
Lymphoid organs were incubated with Collagenase D (Worthington) and
EDTA, and stained with anti–CD11c-PE and anti–PE-microbeads (Miltenyi
Biotec). CD11c
  cells were enriched via application of a magnetic field.
For flow cytometric analysis cells were blocked with FcBlock (2.4G2; BD
Biosciences) and stained with the relevant antibodies (all obtained from
BD Biosciences). Experiments were done on a FACSCalibur and analyzed
using CellQuest software (Becton Dickinson).
CHS responses
To elicit CHS mice were sensitized with 50  l 1% TNCB (a gift from K.
Mahnke, University of Heidelberg, Heidelberg, Germany) in acetone/ol-
ive oil (AOO) 4:1 on the shaved abdomen and challenged 5 d later with
20  l 0.5% TNCB in AOO on the back of the right ear. The left ear was
untreated and swelling responses were measured as the difference be-
tween left and right ears at 24 and 48 h after challenge. To investigate
ear swelling responses in the absence of LC, Langerin-DTR mice were in-
jected with 400 ng DT i.p. 72 h before sensitization. In initial experiments
we have excluded the possibility that untreated Langerin-DTR mice have
an intrinsically lower capacity to mount a CHS response.
Online supplemental material
Fig. S1 demonstrates wt numbers of LC in Langerin-DTR mice, Fig. S2
provides a dose titration of DT to deplete LC, and Fig. S3 shows the pres-
ence or absence of EGFP
  cells in thymus and spleen. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/
jcb.200501071/DC1.
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